ReNeuron Group (RENE) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock RENE Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period TRADING UPDATES: PetroTal buys Peru's Block 131 for USD5.0 millionMay 17, 2024 | lse.co.ukReNeuron CFO steps down to pursue other opportunitiesApril 17, 2024 | lse.co.ukMedtech firm IQ Endoscopes plans to create 100 new jobs and raise millionsApril 2, 2024 | msn.comUpland Resources shares soar as company prepares for Sarawak drillingMarch 28, 2024 | lse.co.ukCompany given millions of public money in Welsh Gov's disastrous foray into biotech investments collapses into administrationMarch 22, 2024 | msn.comTRADING UPDATES: ReNeuron appoints administrators as rescue talks failMarch 20, 2024 | lse.co.ukReNeuron Group PLC RENEFebruary 21, 2024 | morningstar.comMTrident Royalties secures USD40 million revolving credit facilityFebruary 19, 2024 | lse.co.ukTRADING UPDATES: ReNeuron warns; Gama Aviation pledges cash returnFebruary 5, 2024 | lse.co.ukReneuron issues administration warning as biotech firm puts jobs at riskFebruary 5, 2024 | msn.comReNeuron interim loss narrows on lower costs; eyes partnershipsNovember 8, 2023 | lse.co.ukReNeuron Group plc (LON:RENE): Is Breakeven Near?September 18, 2023 | finance.yahoo.comReNeuron Group Slides As Insider Purchases Lose Another UK£75kMay 19, 2023 | finance.yahoo.comReNeuron Group Slides As Insider Purchases Lose Another UK£75k \May 19, 2023 | finance.yahoo.com2023 Neuronal Cell Culture Media Market Size and Research Report in Medical Devices & Consumables Sector | with [104 Pages] and Forecast till 2031May 16, 2023 | marketwatch.comGlobal Retinitis Pigmentosa Treatment & Management Market Report 2023-2030: Top Growth Opportunities and TrendsMay 13, 2023 | marketwatch.comCritical Limb Ischemia Drug Market Size by 2031April 27, 2023 | marketwatch.comPlacental Stem Cell Therapy Market [2023-2030]: Detailed Growth AnalysisApril 20, 2023 | marketwatch.comStem Cell Therapy Market Size, Revenue, and Forecast 2030April 7, 2023 | marketwatch.comGlobal Market for Stem Cells 2023: Potential as Disease Treatment Options Fuels Market MomentumMarch 28, 2023 | uk.finance.yahoo.comGlobal Market for Stem CellsMarch 21, 2023 | uk.finance.yahoo.comReNeuron to present at Advanced Therapies 2023 conferenceMarch 13, 2023 | proactiveinvestors.comReNeuron Group’s investment potential ‘remains intact’, 2024 cash runway secured, says LiberumFebruary 13, 2023 | proactiveinvestors.comReNeuron Group Cuts 40% of Staff, Cash Extended into 2024January 19, 2023 | marketwatch.comRetinitis Pigmentosa (Retinitis) Market Massive Growth Strikes Due To Technological Innovation During 2023-2028January 5, 2023 | marketwatch.comReNeuron Group PLC: Chairman takes the reins as CEO steps downJanuary 3, 2023 | proactiveinvestors.comReNeuron CEO Catherine Isted Steps Down; Iain Ross Appointed ChairmanJanuary 3, 2023 | marketwatch.comReNeuron Group: chairman takes the reins as CEO steps downJanuary 3, 2023 | proactiveinvestors.comReNeuron Group (RENE): Pushing on with CustomEx in H123December 7, 2022 | finance.yahoo.comReNeuron Group First Half 2023 Earnings: UK£0.056 loss per share (vs UK£0.092 loss in 1H 2022)December 4, 2022 | finance.yahoo.comReNeuron Says New Data From CustomEx Platform Supports Monetization StrategyOctober 7, 2022 | marketwatch.comReNeuron Group data points to effectiveness of its ground-breaking technologyOctober 7, 2022 | proactiveinvestors.comReNeuron Appoints New CFOSeptember 15, 2022 | marketwatch.comReNeuron Group names John Hawkins as chief financial officer in boardroom reshuffleSeptember 14, 2022 | proactiveinvestors.comReNeuron Group plc (RENE.L)August 25, 2022 | uk.finance.yahoo.comSMALL CAP IDEA: ReNeuron finance boss says changes at biotech research firm mirror previous roleAugust 22, 2022 | msn.comReNeuron CEO: 'We have a great company that just needed a shake-up'August 22, 2022 | proactiveinvestors.comReNeuron Group Names CFO Catherine Isted as CEOAugust 2, 2022 | marketwatch.comEXECUTIVE CHANGES: ReNeuron promotes CFO Catherine Isted to CEO roleAugust 1, 2022 | lse.co.ukReNeuron Group plc (RNUGF) Management on Q4 2022 Results - Earnings Call TranscriptJuly 5, 2022 | seekingalpha.comStem Cell Market Size Analysis Report 2022 by Manufacturing Base Distribution, Sales Area and Product Type by Player and Forecasts to 2029April 13, 2022 | marketwatch.comReNeuron Group PLC (RQE1.SG)March 30, 2022 | finance.yahoo.comInsiders who bought in the last 12 months lose an additional UK£36k as ReNeuron Group plc (LON:RENE) drops to UK£17mMarch 1, 2022 | finance.yahoo.comReNeuron CEO Olav Hellebo Steps DownFebruary 11, 2022 | marketwatch.comReNeuron shares dive as it drops retinitis pigmentosa trialsJanuary 18, 2022 | lse.co.ukReNeuron to Exit Retinitis Pigmentosa Therapy Trials; Shares DiveJanuary 18, 2022 | marketwatch.comReNeuron re-appoints Randolph Corteling in senior research roleJanuary 11, 2022 | lse.co.ukReNeuron Group plc : Director DeclarationDecember 19, 2021 | markets.businessinsider.comHere's Why We're Not At All Concerned With ReNeuron Group's (LON:RENE) Cash Burn SituationOctober 26, 2021 | finance.yahoo.comDirector dealings: Reneuron Group non-executive makes share purchaseOctober 23, 2021 | lse.co.uk Get ReNeuron Group News Delivered to You Automatically Sign up to receive the latest news and ratings for RENE and its competitors with MarketBeat's FREE daily newsletter. Email Address RENE Media Mentions By Week RENE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RENE News Sentiment▼0.000.42▲Average Medical News Sentiment RENE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RENE Articles This Week▼00▲RENE Articles Average Week Get ReNeuron Group News Delivered to You Automatically Sign up to receive the latest news and ratings for RENE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies EARNZ News Today Marechale Capital News Today Ashtead Group News Today Beximco Pharmaceuticals News Today Land Securities Group News Today Taylor Wimpey News Today Safestore News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:RENE) was last updated on 8/6/2025 by MarketBeat.com Staff From Our Partners[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredGuess Who the Gvt Could Partner With Next?The Government Just Made a $400M Bet. Who's Next? A $100 trillion wealth shift is quietly underway... and t...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReNeuron Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share ReNeuron Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RENE Stock Alerts